Old Web
English
Sign In
Acemap
>
Paper
>
Upfront maintenance with anti-vascular versus PARP inhibitors in advanced ovarian cancer: A cost-effective analysis
Upfront maintenance with anti-vascular versus PARP inhibitors in advanced ovarian cancer: A cost-effective analysis
2020
M Richardson
Daniel S. Kapp
J.E. Chan
S.Y. Liang
A.K. Mann
Bradley J. Monk
Thomas J. Herzog
David S. Lakomy
Robert L. Coleman
J.K. Chan
Keywords:
advanced ovarian cancer
Internal medicine
Poly ADP ribose polymerase
Oncology
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
2
Citations
NaN
KQI
[]